Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evogliptin vs Linagliptin in Type 2 Diabetes
NCT02974504Phase 4Completed
- Sponsor
- Dong-A ST
- Start
- Sep 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of DA5221-B2 in type 2 diabetes mellitus (T2DM), sponsored by Dong-A ST. Started Sep 2016; status: completed.
02
Drugs
DA5221-B2
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02974504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02974504.